Statement on Glucagen Hypokit supply 2 August 2023 Novo Nordisk has notified the Therapeutic Goods Administration that the Glucagen Hypokit is currently in a shortage that will last until 30 September 2023. The Glucagen Hypokit is used to treat severe hypoglycaemia where a person is unconscious or unable to take oral hypo treatments. If a person has a severe hypo and you don’t have a Hypokit you need to call 000 immediately. Diabetes Australia is working with the diabetes sector and the TGA to ensure people at highest risk are prioritized access to available supply. The TGA have also activated Section 19A provisions and is arranging imports of Hypokits from other countries. If you have concerns please talk to someone from your diabetes healthcare team.
News 13 September 2024 Health Check and Tech Diabetes Australia RN/CDE Carolien Koreneff does a finger prick test on Cook MP Simon Kennedy during the Health Checks and... Continue Reading
Media releases 4 September 2024 New Australian Diabetes Clinical Trials Network will change lives Image: (L-R) Keren Pointon, Dr Lisa Hayes, Dr Anish Menon, Prof Elif Ekinci, Justine Cain, Susan Kozij, Prof David O’Neal,... Continue Reading
Blog 6 August 2024 Medications for respiratory tract infections: The good, the unreliable, and the old fashioned Your respiratory tract is made up of an upper section (mouth, throat, nose, sinuses and vocal cords) and a lower... Continue Reading
